18.400
−0,54%
2026-10-19
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +8.0% | +34.3% | 3 / 3 | +4.1% | -0.86 pp | +0.83 pp | +30.7% | 0.27 | 3.19 | 134 | +4,1% | 31,3 | +8,0% | 3.19 | 8.84 | −64,0% |
| Pts | 0 | 4 | 12 | 0 | 4 | 8 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 18.400 (close price on 2026-10-19)EPS (TTM): 5.776
Financial charts
1.Revenue & growth
VND bn134Q2/26
1.Revenue & growth
VND bn134Q2/26
2.Profit & growth
VND bn31,3Q2/26
3.Profit mix (Penman)
VND bn197Q2/26
4.Margins & cost structure
%33.3%Q2/26
5.Returns & cash cycle
% · days28.9%Q2/26
6.Earnings quality & cash
VND bn220Q2/26
7.Asset structure
VND bn1.100Q2/26
8.Funding & debt health
VND bn · times1.100Q2/26
9.Revenue backlog
VND bn131Q2/26
10.Valuation
times · %3,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.174Q2/26
Adjusted EPS growth, latest quarter
8.0%
Average adjusted EPS growth, 3 quarters
34.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26